COO logo

Cooper Companies (COO)

Profile

Full Name

The Cooper Companies, Inc.

Ticker Symbol

COO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

January 21, 1983

Indexes

S&P 500

Website

http://www.coopercos.com

Employees

16000

Key Details

Price

$77.80(-1.22%)

Market cap

Last Dividend

$0.01

TTM Dividend yield

-

Annual revenue

$3.90B(+8.41% YoY)

Annual EPS

$1.96(+32.43% YoY)

PE ratio

37.77

Next earnings date

May 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$77.80
COO price is $77.80

30-Day Relative Volume

0.55
COO 30-day relative volume is 0.55

Price Performance

Price Today change

-1.22%
COO price is down -1.22% today

Price YTD change

-15.37%
COO price is down -15.37% since January 1st

Price 1-year change

-15.47%
COO price is down -15.47% year-on-year

Price 3-year change

-22.13%
COO price is down -22.13% over the past 3 years

Price Range

Price All-time high

$115.90
COO price is currently -32.87% below its historical high of $115.90

Price 3-year low

$61.05
COO price is currently +27.43% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$15.56B
COO market capitalization is $15.56 billion

Market cap 3-year change

-21.04%
COO market capitalization is down -21.04% over the past 3 years

Market cap All-time high

$22.48B
COO market capitalization is currently -30.79% below its historical high of $22.48 billion

Market cap sector rank

94.98%
COO market capitalization is higher than 94.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.6%
COO shares outstanding is up +0.6% year-on-year

Shares Outstanding 3-Year Change

+1.39%
COO shares outstanding is up +1.39% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.69
COO beta is 0.69

200-day SMA

$95.30
COO price is currently -18.36% below its 200-day simple moving average

50-day SMA

$84.92
COO price is currently -8.39% below its 50-day simple moving average

RSI

44.44
COO 14-day relative strength index is 44.44

Volume

0.55
COO 30-day relative volume is 0.55

ATR

$3.31
COO average true range is $3.31

10-day Historical Volatility

65.61%
COO 10-day historical volatility is 65.61%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.01
COO last dividend was $0.01 per share, with an ex-dividend date of July 26, 2023

Next Dividend

-
COO next dividend has not yet been announced

Dividend per share

Dividend per share

-
COO annual dividend per share value is unknown

Dividend per share Sector Rank

-
COO annual dividend per share is unknown

Dividend per share 1-Year Change

-
COO annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
COO annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
COO annual dividend yield value is unknown

Dividend yield Sector Rank

-
COO annual dividend yield is unknown

Other

Payout ratio

0.00%
COO annual payout ratio is 0.00%

Dividends paid

$0.00
COO annual dividends paid is $0.00

Free cash flow

$288.10M
COO annual free cash flow is $288.10 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.90B
COO annual revenue is $3.90 billion

Revenue Analysts estimate

$4.12B
COO annual revenue is currently -5.39% lower than the consensus analysts' forecast

Revenue 1-year change

+8.41%
COO annual revenue is up +8.41% year-on-year

Revenue Sector rank

90.26%
COO annual revenue is higher than 90.26% of companies in Healthcare sector

EPS

EPS

$1.96
COO annual earnings per share is $1.96

EPS Analysts estimate

$3.99
COO annual earnings per share is currently -50.82% lower than the consensus analysts' forecast

EPS 1-year change

+32.43%
COO annual earnings per share is up +32.43% year-on-year

EPS Sector rank

92.14%
COO annual earnings per share is higher than 92.14% of companies in Healthcare sector

Profit

Gross profit

$2.60B
COO annual gross profit is $2.60 billion

Gross margin

66.64%
COO annual gross profit margin is 66.64%

Operating profit

$705.70M
COO annual operating income is $705.70 million

Operating margin

18.12%
COO annual operating profit margin is 18.12%

Net income

$392.30M
COO annual net profit is $392.30 million

Net margin

10.07%
COO annual net profit margin is 10.07%

Expenses

Total expenses

$3.19B
COO annual total expenses is $3.19 billion

Operating expenses

$1.89B
COO annual total operating expenses is $1.89 billion

Cost of goods sold

$1.30B
COO annual cost of goods sold is $1.30 billion

Selling, general & administrative expenses

$1.53B
COO annual SGA is $1.53 billion

Depreciation and amortization

$375.10M
COO annual depreciation & amortization is $375.10 million

Interest expense

$114.30M
COO annual interest expense is $114.30 million

Income tax

$190.00M
COO annual income tax is $190.00 million

EBIT & EBITDA

EBIT

$696.60M
COO annual earnings before interest & taxes is $696.60 million

EBITDA

$897.80M
COO annual EBITDA is $897.80 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.32B
COO annual total assets is $12.32 billion

Non current assets

$10.36B
COO annual long term assets is $10.36 billion

Current assets

$1.95B
COO annual total current assets is $1.95 billion

Cash and cash equivalents

$107.60M
COO annual cash & cash equivalents is $107.60 million

Accounts receivable

$717.00M
COO annual accounts receivable is $717.00 million

Inventory

$802.70M
COO annual inventory is $802.70 million

Liabilities

Total liabilities

$4.23B
COO annual total liabilities is $4.23 billion

Long term liabilities

$3.21B
COO annual total long term liabilities is $3.21 billion

Current liabilities

$1.02B
COO annual total current liabilities is $1.02 billion

Accounts payable

$260.50M
COO annual accounts payable is $260.50 million

Debt

Total debt

$2.58B
COO annual total debt is $2.58 billion

Total debt 1-year change

+0.56%
COO annual total debt is up +0.56% year-on-year

Long term debt

$2.55B
COO annual long term debt is $2.55 billion

Short term debt

$33.30M
COO annual short term debt is $33.30 million

Equity & Capital

Shareholders equity

$8.08B
COO annual stockholders equity is $8.08 billion

Book value

$8.08B
COO annual book value is $8.08 billion

Retained earnings

$7.27B
COO annual retained earnings is $7.27 billion

Working capital

$928.70M
COO annual working capital is $928.70 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$709.30M
COO annual cash flow from operations is $709.30 million

Cash from operations 1-year change

+16.76%
COO annual cash flow from operations is up +16.76% year-on-year

Cash from investing

-$764.60M
COO annual cash flow from investing activities is -$764.60 million

Cash from investing 1-year change

-70.29%
COO annual cash flow from investing activities is down -70.29% year-on-year

Cash from financing

$39.20M
COO annual cash flow from financing activities is $39.20 million

Cash from financing 1-year change

+122.54%
COO annual cash flow from financing activities is up +122.54% year-on-year

CAPEX

CAPEX

$421.20M
COO annual capital expenditures is $421.20 million

CAPEX 1-year change

+7.31%
COO annual capital expenditures is up +7.31% year-on-year

Free Cash Flow

Free cash flow

$288.10M
COO annual free cash flow is $288.10 million

Free cash flow 1-year change

+34%
COO annual free cash flow is up +34% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

66.64%
COO annual gross profit margin is 66.64%

Operating margin

18.12%
COO annual operating profit margin is 18.12%

Net margin

10.07%
COO annual net profit margin is 10.07%

ROA & ROE

ROA

3.27%
COO annual return on assets is 3.27%

ROE

5.02%
COO annual return on equity is 5.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

37.77
COO price to earnings ratio is 37.77

PE ratio Sector rank

69.61%
COO price to earnings ratio is higher than 69.61% of companies in Healthcare sector

PB Ratio

PB ratio

1.91
COO price to book ratio is 1.91

PB ratio Sector rank

61.15%
COO price to book ratio is higher than 61.15% of companies in Healthcare sector

PS Ratio

PS ratio

3.96
COO price to sales ratio is 3.96

PS ratio Sector rank

61.15%
COO price to sales ratio is higher than 61.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$18.00B
COO enterprise value is $18.00 billion

Enterprise value Sector rank

94.46%
COO enterprise value is higher than 94.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

16.43
COO EV/EBITDA is 16.43

EV/EBITDA Sector rank

89.13%
COO EV/EBITDA is higher than 89.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.91
COO annual current ratio is 1.91

Quick ratio

1.12
COO annual quick ratio is 1.12

Leverage

Debt to equity

0.32
COO annual debt to equity ratio is 0.32

Interest coverage ratio

6.09
COO annual interest coverage ratio is 6.09

Risk & Stability

Piotroski F-Score

8
COO piotroski f-score is 8

Altman Z-Score

3.63
COO altman z-score is 3.63

Analyst ratings

Recent major analysts updates

Mar 7, 25 Stifel
Buy
Mar 7, 25 Piper Sandler
Overweight
Mar 7, 25 Needham
Hold
Mar 7, 25 JP Morgan
Overweight
Mar 7, 25 Citigroup
Buy
Mar 7, 25 Baird
Outperform
Dec 6, 24 Wells Fargo
Overweight
Dec 6, 24 Needham
Hold
Dec 6, 24 Morgan Stanley
Equal-Weight
Dec 6, 24 Citigroup
Buy

Institutional Ownership

Similar stocks

TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
WST logo
West Pharmaceutical Services (WST)
FMS logo
Fresenius Medical Care AG & Co KGaA (FMS)
BAX logo
Baxter International (BAX)
RPRX logo
Royalty Pharma (RPRX)
ITCI logo
Intra-Cellular Therapies (ITCI)
BIIB logo
Biogen (BIIB)
PODD logo
Insulet (PODD)
HOLX logo
Hologic (HOLX)
  • What is the ticker symbol for Cooper Companies?
  • Does Cooper Companies pay dividends?
  • What sector is Cooper Companies in?
  • What industry is Cooper Companies in?
  • What country is Cooper Companies based in?
  • When did Cooper Companies go public?
  • Is Cooper Companies in the S&P 500?
  • Is Cooper Companies in the NASDAQ 100?
  • Is Cooper Companies in the Dow Jones?
  • When was Cooper Companies's last earnings report?
  • When does Cooper Companies report earnings?
  • Should I buy Cooper Companies stock now?

What is the ticker symbol for Cooper Companies?

The ticker symbol for Cooper Companies is NASDAQ:COO

Does Cooper Companies pay dividends?

No, Cooper Companies does not pay dividends

What sector is Cooper Companies in?

Cooper Companies is in the Healthcare sector

What industry is Cooper Companies in?

Cooper Companies is in the Medical Instruments & Supplies industry

What country is Cooper Companies based in?

Cooper Companies is headquartered in United States

When did Cooper Companies go public?

Cooper Companies's initial public offering (IPO) was on January 21, 1983

Is Cooper Companies in the S&P 500?

Yes, Cooper Companies is included in the S&P 500 index

Is Cooper Companies in the NASDAQ 100?

No, Cooper Companies is not included in the NASDAQ 100 index

Is Cooper Companies in the Dow Jones?

No, Cooper Companies is not included in the Dow Jones index

When was Cooper Companies's last earnings report?

Cooper Companies's most recent earnings report was on Mar 6, 2025

When does Cooper Companies report earnings?

The next expected earnings date for Cooper Companies is May 29, 2025

Should I buy Cooper Companies stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page